insights_auto
为什么 TNDM 上涨了 2.78%?
深入探索chevron_right
TNDM:NASDAQ
Tandem Diabetes Care Inc
US$16.11
arrow_upward
+2.78%(+0.44) 1 天
US$16.11
0.00% (0.00)
bedtime盘后交易
休市： 10月9日, GMT-4 16:00:00 · USD
search
所有股票代码
| 股票代码 | 价格 | 涨跌额 | 涨跌幅 |
|---|
insights_auto正在为 TNDM 生成关键数据洞见…
开盘价
US$15.64
最高价
US$16.13
最低价
US$15.38
市值
11.21亿
平均成交量
204.12万
成交量
143.01万
52 周最高价
US$29.65
52 周最低价
US$12.26
每股收益
-US$0.93
Beta 版
1.66
流通股数
6957.90万
员工人数
2500
开盘价
US$15.64
最高价
US$16.13
最低价
US$15.38
市值
11.21亿
平均成交量
204.12万
成交量
143.01万
52 周最高价
US$29.65
52 周最低价
US$12.26
每股收益
-US$0.93
Beta 版
1.66
流通股数
6957.90万
员工人数
2500
新闻报道
来自网络来源和新闻合作伙伴
资料
Tandem Diabetes Care, Inc. is an American medical-device company that develops and markets insulin pumps, automated insulin delivery systems and diabetes-management software. Headquartered in San Diego, California, its principal pump platforms are the t:slim X2 and Tandem Mobi, both of which use the company's Control-IQ+ software with compatible continuous glucose monitors.
Tandem was founded in 2006 and introduced its first pump, the touchscreen t:slim, in 2012. The company became publicly traded on the Nasdaq in 2013. By the end of 2025 it reported an in-warranty user base of nearly 500,000 people in more than 25 countries and annual sales of $1.015 billion. Wikipedia
Tandem Diabetes Care Inc简介